# Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

> **NCT06291363** · PHASE4 · RECRUITING · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 64 (estimated)

## Conditions studied

- Opioid Use, Unspecified
- Anesthesia
- Nociceptive Pain

## Interventions

- **DRUG:** Esmolol Hydrochloride
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06291363
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-16
- **Primary completion:** 2025-03-03
- **Final completion:** 2025-03-04
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06291363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06291363, "Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06291363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*